356 related articles for article (PubMed ID: 16918944)
1. Testosterone treatment comes of age: new options for hypogonadal men.
Nieschlag E
Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944
[TBL] [Abstract][Full Text] [Related]
2. Testosterone supplementation: what and how to give.
Jockenhövel F
Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
[TBL] [Abstract][Full Text] [Related]
3. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
Asscheman H; Gooren LJ
Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
5. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
Seftel A
Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement therapy: current trends and future directions.
Nieschlag E; Behre HM; Bouchard P; Corrales JJ; Jones TH; Stalla GK; Webb SM; Wu FC
Hum Reprod Update; 2004; 10(5):409-19. PubMed ID: 15297434
[TBL] [Abstract][Full Text] [Related]
8. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
von Eckardstein S; Nieschlag E
J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
[TBL] [Abstract][Full Text] [Related]
9. Testosterone undecanoate in the treatment of male hypogonadism.
Edelstein D; Basaria S
Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
[TBL] [Abstract][Full Text] [Related]
10. Testosterone release rate and duration of action of testosterone pellet implants.
Kelleher S; Howe C; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
[TBL] [Abstract][Full Text] [Related]
11. Transdermal androgens: pharmacology and applicability to hypogonadal elderly men.
Swerdloff RS; Wang C
J Endocrinol Invest; 2005; 28(3 Suppl):112-6. PubMed ID: 16042369
[TBL] [Abstract][Full Text] [Related]
12. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
[TBL] [Abstract][Full Text] [Related]
14. Androgen replacement therapy: present and future.
Gooren LJ; Bunck MC
Drugs; 2004; 64(17):1861-91. PubMed ID: 15329035
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
[TBL] [Abstract][Full Text] [Related]
16. Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.
Meikle AW; Matthias D; Hoffman AR
BJU Int; 2004 Apr; 93(6):789-95. PubMed ID: 15049991
[TBL] [Abstract][Full Text] [Related]
17. Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P
Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in the treatment of testosterone deficiency syndrome.
Hong BS; Ahn TY
Int J Urol; 2007 Nov; 14(11):981-5. PubMed ID: 17956520
[TBL] [Abstract][Full Text] [Related]
19. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
Fennell C; Sartorius G; Ly LP; Turner L; Liu PY; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):102-9. PubMed ID: 19891698
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
Turchi P; Simi S; Pescatori ES
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
